ICU Medical, Inc. (NASDAQ:ICUI) Director Joseph R. Saucedo sold 9,000 shares of the business’s stock in a transaction that occurred on Monday, October 9th. The shares were sold at an average price of $189.46, for a total transaction of $1,705,140.00. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

ICU Medical, Inc. (ICUI) opened at 186.35 on Friday. ICU Medical, Inc. has a one year low of $127.00 and a one year high of $192.65. The stock’s 50 day moving average is $181.38 and its 200 day moving average is $168.29. The firm has a market capitalization of $3.69 billion, a P/E ratio of 74.63 and a beta of 0.35.

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.52 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.58 by ($0.06). The company had revenue of $331.51 million for the quarter, compared to analysts’ expectations of $318.30 million. ICU Medical had a net margin of 6.10% and a return on equity of 7.56%. The business’s quarterly revenue was up 242.8% compared to the same quarter last year. During the same quarter last year, the business posted $1.15 EPS. On average, equities research analysts predict that ICU Medical, Inc. will post $4.11 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: This story was originally published by Watch List News and is the property of of Watch List News. If you are viewing this story on another domain, it was illegally stolen and republished in violation of US and international copyright and trademark legislation. The original version of this story can be read at https://www.watchlistnews.com/insider-selling-icu-medical-inc-icui-director-sells-1705140-00-in-stock/1627176.html.

Several research analysts have commented on ICUI shares. Zacks Investment Research upgraded shares of ICU Medical from a “hold” rating to a “buy” rating and set a $193.00 price objective for the company in a research report on Thursday, July 20th. Gabelli reiterated a “buy” rating on shares of ICU Medical in a report on Friday, August 11th. BidaskClub upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a report on Saturday, June 17th. Finally, Sidoti downgraded shares of ICU Medical from a “buy” rating to a “neutral” rating in a report on Tuesday, June 20th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the company. ICU Medical has a consensus rating of “Hold” and an average target price of $193.00.

Institutional investors have recently bought and sold shares of the company. Personal Capital Advisors Corp purchased a new stake in shares of ICU Medical during the 2nd quarter valued at $1,494,000. Fiera Capital Corp purchased a new stake in shares of ICU Medical during the 2nd quarter valued at $36,962,000. Royce & Associates LP raised its position in shares of ICU Medical by 26.7% during the 2nd quarter. Royce & Associates LP now owns 47,400 shares of the medical instruments supplier’s stock valued at $8,177,000 after buying an additional 10,000 shares in the last quarter. Citigroup Inc. raised its position in shares of ICU Medical by 104.3% during the 2nd quarter. Citigroup Inc. now owns 17,190 shares of the medical instruments supplier’s stock valued at $2,965,000 after buying an additional 8,775 shares in the last quarter. Finally, Schwab Charles Investment Management Inc. raised its position in shares of ICU Medical by 8.4% during the 1st quarter. Schwab Charles Investment Management Inc. now owns 62,048 shares of the medical instruments supplier’s stock valued at $9,475,000 after buying an additional 4,829 shares in the last quarter. Hedge funds and other institutional investors own 78.13% of the company’s stock.

About ICU Medical

ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

Insider Buying and Selling by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.